Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Serosurveillance of vaccine preventable diseases and hepatitis C in healthcare workers from Lao PDR.

Black AP, Vilivong K, Nouanthong P, Souvannaso C, Hübschen JM, Muller CP.

PLoS One. 2015 Apr 14;10(4):e0123647. doi: 10.1371/journal.pone.0123647. eCollection 2015.

2.

Hepatitis B virus in the Lao People's Democratic Republic: a cross sectional serosurvey in different cohorts.

Black AP, Nouanthong P, Nanthavong N, Souvannaso C, Vilivong K, Jutavijittum P, Samountry B, Lütteke N, Hübschen JM, Goossens S, Quet F, Buisson Y, Muller CP.

BMC Infect Dis. 2014 Aug 23;14:457. doi: 10.1186/1471-2334-14-457.

3.

Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium.

Theeten H, Hutse V, Hens N, Yavuz Y, Hoppenbrouwers K, Beutels P, Vranckx R, Van Damme P.

Epidemiol Infect. 2011 Apr;139(4):494-504. doi: 10.1017/S0950268810001536. Epub 2010 Jun 29.

PMID:
20587123
4.

Seroprotection against Vaccine-Preventable Diseases amongst Health Care Workers in a Community Hospital, Qatar.

Guanche Garcell H, Villanueva Arias A, Guilarte García E, Alfonso Serrano RN.

Int J Occup Environ Med. 2016 Oct;7(4):234-40. doi: 10.15171/ijoem.2016.864.

5.

Seroprevalence of vaccine-preventable diseases among young children in the United Arab Emirates.

Al-Mekaini LA, Kamal SM, Al-Jabri O, Soliman M, Alshamsi H, Narchi H, Souid AK, Alsuwaidi AR.

Int J Infect Dis. 2016 Sep;50:67-71. doi: 10.1016/j.ijid.2016.07.012. Epub 2016 Jul 22.

6.

Seroprevalence and vaccination coverage of vaccine-preventable diseases in perinatally HIV-1-infected patients.

Sticchi L, Bruzzone B, Caligiuri P, Rappazzo E, Lo Casto M, De Hoffer L, Gustinetti G, Viscoli C, Di Biagio A.

Hum Vaccin Immunother. 2015;11(1):263-9. doi: 10.4161/hv.36162. Epub 2014 Nov 1.

7.

Low and disparate seroprotection after pentavalent childhood vaccination in the Lao People's Democratic Republic: a cross-sectional study.

Evdokimov K, Sayasinh K, Nouanthong P, Vilivong K, Samountry B, Phonekeo D, Strobel M, Haegeman F, Heimann P, Muller CP, Black AP.

Clin Microbiol Infect. 2017 Mar;23(3):197-202. doi: 10.1016/j.cmi.2016.10.007. Epub 2016 Oct 15.

8.

Hepatitis B and C: neglected diseases among health care workers in Cameroon.

Fritzsche C, Becker F, Hemmer CJ, Riebold D, Klammt S, Hufert F, Akam W, Kinge TN, Reisinger EC.

Trans R Soc Trop Med Hyg. 2013 Mar;107(3):158-64. doi: 10.1093/trstmh/trs087. Epub 2013 Jan 8.

PMID:
23303802
9.

Evaluation of nationwide supplementary immunization in Lao People's Democratic Republic: Population-based seroprevalence survey of anti-measles and anti-rubella IgG in children and adults, mathematical modelling and a stability testing of the vaccine.

Hachiya M, Miyano S, Mori Y, Vynnycky E, Keungsaneth P, Vongphrachanh P, Xeuatvongsa A, Sisouk T, Som-Oulay V, Khamphaphongphane B, Sengkeopaseuth B, Pathammavong C, Phounphenghak K, Kitamura T, Takeda M, Komase K.

PLoS One. 2018 Mar 29;13(3):e0194931. doi: 10.1371/journal.pone.0194931. eCollection 2018.

10.

Varicella zoster and fever rash surveillance in Lao People's Democratic Republic.

Nouanthong P, Hübschen JM, Billamay S, Mongkhoune S, Vilivong K, Khounvisith V, Sinner R, Grandadam M, Phonekeo D, Black AP, Muller CP.

BMC Infect Dis. 2019 May 8;19(1):392. doi: 10.1186/s12879-019-3990-7.

11.

Immunity against vaccine-preventable diseases in Finnish pediatric healthcare workers in 2015.

Koivisto K, Puhakka L, Lappalainen M, Blomqvist S, Saxén H, Nieminen T.

Vaccine. 2017 Mar 14;35(12):1608-1614. doi: 10.1016/j.vaccine.2017.02.018. Epub 2017 Feb 21.

PMID:
28233625
12.

Seroprevalence survey of varicella, measles, rubella, and hepatitis A and B viruses in a multinational healthcare workforce in Saudi Arabia.

Almuneef MA, Memish ZA, Balkhy HH, Otaibi B, Helmi M.

Infect Control Hosp Epidemiol. 2006 Nov;27(11):1178-83. Epub 2006 Oct 17.

PMID:
17080374
13.

Seroprevalence of measles, mumps, rubella, varicella-zoster and hepatitis A-C in Emirati medical students.

Sheek-Hussein M, Hashmey R, Alsuwaidi AR, Al Maskari F, Amiri L, Souid AK.

BMC Public Health. 2012 Dec 5;12:1047. doi: 10.1186/1471-2458-12-1047.

14.

Pediatric disease burden and vaccination recommendations: understanding local differences.

Gentile A, Bhutta Z, Bravo L, Samy AG, Garcia RD, Hoosen A, Islam T, Karimi A, Salem M, Simasathien S, Sohail A, Watanaveeradej V, Wiedenmayer K, Schmitt HJ.

Int J Infect Dis. 2010 Aug;14(8):e649-58. doi: 10.1016/j.ijid.2009.11.006. Epub 2010 Feb 23.

15.

Serologic testing of randomly selected children after hepatitis B vaccination: a cross-sectional population-based study in Lao People's Democratic Republic.

Norizuki M, Kitamura T, Komada K, Sugiyama M, Mizokami M, Xeuatvongsa A, Som-Oulay V, Vongphrachanh P, Machida M, Wada K, Ishii K, Kiyohara T, Wakita T, Hachiya M.

BMC Infect Dis. 2019 Jun 10;19(1):507. doi: 10.1186/s12879-019-4086-0.

16.

Exposure of Ugandan health personnel to measles and rubella: evidence of the need for health worker vaccination.

Lewis RF, Braka F, Mbabazi W, Makumbi I, Kasasa S, Nanyunja M.

Vaccine. 2006 Nov 17;24(47-48):6924-9. Epub 2006 Jun 28.

PMID:
17014938
17.

Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional study.

Heijstek MW, van Gageldonk PG, Berbers GA, Wulffraat NM.

Ann Rheum Dis. 2012 Jun;71(6):948-54. doi: 10.1136/annrheumdis-2011-200637. Epub 2011 Dec 15.

PMID:
22172491
18.

Vaccination status of children considered for renal transplants: missed opportunities for vaccine preventable diseases.

Genc G, Ozkaya O, Aygun C, Yakupoglu YK, Nalcacioglu H.

Exp Clin Transplant. 2012 Aug;10(4):314-8.

19.

Immunity against measles, mumps, rubella, varicella, diphtheria, tetanus, polio, hepatitis A and hepatitis B among adult asylum seekers in the Netherlands, 2016.

Freidl GS, Tostmann A, Curvers M, Ruijs WLM, Smits G, Schepp R, Duizer E, Boland G, de Melker H, van der Klis FRM, Hautvast JLA, Veldhuijzen IK.

Vaccine. 2018 Mar 14;36(12):1664-1672. doi: 10.1016/j.vaccine.2018.01.079. Epub 2018 Feb 14.

20.

Supplemental Content

Support Center